Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

UnitedHealth Group (NY:UNH)

523.20 +0.08 (+0.02%)
Official Closing Price Updated: 7:00 PM EDT, Apr 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about UnitedHealth Group

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
79 80 Next >
Chipmaker Stocks Sink On ASML Earnings Leak, Oil Eyes Worst 1-Day Drop This Year, Small Caps Rally: What's Driving Markets Tuesday?
A wave of market-relevant news fueled an active trading session on Wall Street Tuesday, with large-cap indices falling due to sharp declines in tech and energy stocks, while small-caps outperformed,... 
Via Benzinga
Google Goes Nuclear For AI Power, Israeli Restraint Impacts Stocks, Gold, And Oil
To gain an edge, this is what you need to know today. 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
UnitedHealth Group's Earnings Outlook
Via Benzinga
(UNH) - Analyzing UnitedHealth Group's Short Interest
Via Benzinga
Spotlight on UnitedHealth Group: Analyzing the Surge in Options Activity
Via Benzinga
Why Elevance Health (ELV) Shares Are Falling
Elevance Health shares edged lower by 3.5% on Tuesday. Healthcare stocks are trading lower following UnitedHealth Group's Q3 earnings report. 
Via Benzinga
Why CVS Health Stock Is Trading Lower
CVS Health shares are trading lower by 3.8% during Tuesday's session. Health insurer stocks are down after UnitedHealth reported Q3 results and cut its annual EPS outlook. 
Via Benzinga
UnitedHealth Q3 Earnings: Revenue And EPS Beat, Revises Annual Profit Guidance As Change Healthcare Cyberattack Still Bites
UnitedHealth reported Q3 2024 adjusted EPS of $7.15, beating expectations. Revenue grew to $100.8 billion, but the company lowered its full-year EPS guidance due to business disruptions, including a... 
Via Benzinga
UnitedHealth Group Beats Q3 Expectations With $7.15 EPS
UnitedHealth Group reported impressive financial results for the third quarter of 2024, with revenues reaching $100.8 billion. 
Via Talk Markets
UnitedHealth Beats But Reins In Outlook As Costs Rise; UNH Stock Slips
The Dow giant's Optum services unit generated over 50% of operating income. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Wall Street On Edge As Nasdaq Nears Record High, Oil Prices Plummet: Strategist Says There's Opportunity If Resilience Continues
Wall Street mood has become circumspect as traders gear up to receive a slew of earnings reports this week amid the market’s record run. The Nasdaq Composite has been a laggard among the major averages... 
Via Benzinga
Topics Stocks
Exposures US Equities
UnitedHealth Group Reports Third Quarter 2024 Results
From UnitedHealth Group
Via Business Wire
Jim Cramer Says Earnings Season Will Fuel Market's Record Run, But Warns Of This 'Horrendous' Headwind That Could Apply Brakes To Rally
The stock market has been on a two-year strong run and the extended rally has begun to stir valuation concerns. 
Via Benzinga
Citigroup, Bank of America And 3 Stocks To Watch Heading Into Tuesday
Via Benzinga
UnitedHealth Group Q3 Earnings Preview: Dow Jones Industrial Average Stock Could 'Move Markets' Tuesday
United Healthcare reports financial results Tuesday Oct. 15, which could put pressure on the Dow Jones Industrial Average if shares are volatile. 
Via Benzinga
Topics Stocks
Exposures US Equities
Healthcare Sector Update: Life in the Slow Lane while we wait for BIOTECH Bounce
Healthcare sector lags despite moderate growth. Note bad news from CVS and Humana. 
Via Talk Markets
Columbus Day: Is Stock Market Open Today?
Investors should brace for a busy week with earnings reports from major companies. 
Via Benzinga
3 No-Brainer Stocks to Buy If Kamala Harris and Democrats Sweep in November
These stocks should be big winners if Democrats control the White House and both chambers of Congress. 
Via The Motley Fool
Prediction: These Could Be the Best-Performing Value Stocks Through 2030
Value stocks can stabilize your portfolio growth over time. 
Via The Motley Fool
Peeling Back The Layers: Exploring UnitedHealth Group Through Analyst Insights
Via Benzinga
Sustainability Of Energy Stocks Is Clouded By 2024 Election Uncertainty
Here's what investors should know about what's at stake for sustainable companies. 
Via Investor's Business Daily
Here's How Much You Would Have Made Owning UnitedHealth Group Stock In The Last 5 Years
Via Benzinga
Bernie Sanders And AOC Clap Back At Mark Cuban's Push for FCC Chief Shakeup: 'Anyone Goes Near Lina Khan And There Will Be An Out And Out Brawl'
Alexandria Ocasio-Cortez and Bernie Sanders have strongly defended FTC chief Lina Khan and opposed Mark Cuban's suggestions that she be replaced if Kamala Harris becomes president. 
Via Benzinga
Exposures Regulatory
CVS, UnitedHealth Request FTC Chair Recusal Amid Ongoing Pharmacy Benefit Managers Lawsuit
The FTC has filed a formal complaint accusing CVS, Cigna, and UnitedHealth of engaging in anti-competitive practices that inflate insulin prices. The complaint claims the PBMs' focus on rebates raises... 
Via Benzinga
1 Vanguard Index Fund Could Turn $500 Per Month Into a $968,400 Portfolio That Pays $16,000 in Annual Dividend Income
Workers with median earnings can build sizable portfolios that pay hefty amounts of passive income in retirement. 
Via The Motley Fool
UNH: A Solid Healthcare Play In A Rotational Market
The blistering hot theme in markets right now is obviously the China trade, and this means investor capital is being allocated towards the Hang Seng, China ADRs, and for institutions that have access,... 
Via Talk Markets
Biotech Stocks Poised For Another Big Move In Q4
The healthcare sector can be a safe haven if volatility increases. 
Via Talk Markets
Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades
Investors can find market-trouncing blue chip stocks in the healthcare industry. 
Via The Motley Fool
Blue Shield of California Slashes Humira Biosimilar Prices in Landmark Deal
Blue Shield of California partners with Fresenius Kabi and Evio Pharmacy to cut the cost of Humira's biosimilar to $525 per month, with most members paying $0 out of pocket starting January 2025. 
Via Benzinga
UnitedHealthcare Commits $335,000 to Idaho Organizations To Expand Health Care Workforce and Access To Care
From UnitedHealthcare
Via Business Wire
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
79 80 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.